Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases

ABSTRACT: Hypothesis of the study: Neoadjuvant chemotherapy with Bevacizumab impairs postoperative outcome after resection of colorectal liver metastases.

DISEASE(S): Neoplasm Metastasis,Liver Neoplasms,Colorectal Liver Metastases

PROVIDER: 2070323 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR